Get started
NOVAVAX INCNOVAVAX INCNOVAVAX INC

NOVAVAX INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

NVV1 trade ideas

[NVAX] Novavax: Update - 1.6 billion funded!I still believe NVAX has a lot of potential and I'll say it again. My idea is clear that its NanoParticle and Matrix-M Adjuvant tech makes it a prime candidate for a COVID-19 vaccines. Even if it doesn't make it first (or ever), it still has major potential for the seasonal influenza (w/ NanoFlu) and its Respiratory Syncytial Virus (RSV) vaccine. Check out my original post that is linked. Today's News: 1. www.cnbc.com 2. www.fool.com
NASDAQ:NVAXLong
by traderman001
NOVAVAX - long term targetsThese are my thoughts on Novavax. They are meant to give you an idea, not trading advice. As written in the textbooks, gaps in a downtrend always get filled in an uptrend. We already filled gap 1. I believe it's time to start filling gap 2, witch is gigantic. Novavax is receiving a lot of financial support for making a Covid19 vaccin, so expectations are high for now. It's one of the stronger stocks in the market at this moment, working together with Biotechnology. As you can see on the charts, we have formed a similar pattern as we did in April 2020. I don't know how fast gap 2 can get filled, but as soon as we started filing gap 1, things skyrocketed. I'm very excited to see how this will play out, and I hope it can help you. Please note that Novavax is a very volatile stock, things can change very fast over night. Be careful when entering your position in this stock!
NASDAQ:NVAXLong
by AXLP
15
NVAX Long - $150 Target?I've been following NVAX since price was at $12. Fundamentally they have one of the most promising COVID vaccines and their Nano Flu shot beat Sanify's flu shot, whos been a market majority holder in that aspect. Technically, we've tapped that $150+ zone 8 out of the last 9 fast rises over since the company IPO'd in 1996. Each of the rises have been driven by pandemic viruses..ie, swine flu, bird flu, H1N1, etc. We have 4 days until the quarterly candle closes. If we close strong, we'd of closed above the coral, and momentum and RSI are correlating. I think we will see a short term sell off at the psychological $100 level. How much? I could see $80-$85 be a good rebuy zone to push price up to t $125 then $150. Buyers at $80, will probably be looking for a double on their investment which would put price at $160. Let me know what you think!
NASDAQ:NVAXLong
by allout06
7
Novavax (NVAX) stock price is on track...for now [LONG]Just re-iterating my previous assertion (guess) that NVAX is on course for massive gains in the long-term. Doesn't mean it's a great company but this pandemic has initiated a similar pattern in the past. They have several great developments in the works: NanoFlu, RSV F, and a COVID-19 vaccine candidate. See my previous posts especially the related one. This is purely speculation based on their pipeline. This is not financial advice.
NASDAQ:NVAXLong
by traderman001
3
Nvax in depth analysis and view on a stockFundamentals : Previous Close- 44.43 Open- 45.55 Bid- 45.00 x 1300 Ask- 45.40 x 1000 Day's Range- 43.60 - 45.76 52 Week Range- 3.54 - 61.50 Volume- 3,231,807 Avg. Volume- 9,264,854 Market Cap- 2.673B Beta (5Y Monthly)- 1.41 PE Ratio (TTM)- N/A EPS (TTM)- -3.83 Earnings Date- May 10, 2020 Forward Dividend & Yield- N/A (N/A) Ex-Dividend Date- N/A 1y Target Est- 51.80 Stock can surge up in the future because of the news. That does not mean that is a great investment. Nvax is mostly traded intraday, and is not good for longer term. My analysis is only for entertainment only and i do not recommend taking any of my trades because of the risk. I offer stock trading mentorship for free, later i will probably offer paid mentorship. I am a trader at an investment firm. If you have any king of questions feel free to ask. If you need help feel free to ask. If you want to learn more feel free to contact me. If you want to get a funded account up to 280.000$, mentorship and professional knowledge contact me. From May this programs are not available for US residents. BlackStock
NASDAQ:NVAX
by UnknownUnicorn7025460
$NVAX - Gap up playGM traders! Hope you had a nice Memorial Day Weekend. $NVAX gapping up +20% this morning, covid-19 vaccine play, phase 1 clinical trial news. 2 ways to play this: 1. look to short at premarket high and top of resistance area before the daily gap up, anywhere between 58.62 (PM high) and 61.50, target price is premarket low around 53 area. Risk 1: Reward 6 2. look to go long after breaking resistance area, and pull back. +80% gap fill within 2 days, enter near 60 area and target 80. Risk 3: Reward 20
NASDAQ:NVAX
by archi_trader
1
NVAX: $55+ Target very Reasonable, hoping for around $65First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion based basis. That being said, I have a few quick insights. Novavax is about to start the human clinical trials for a Coronavirus vaccine, and the recent already expected price retracement by investors, the strong buy rating, and the positive news may have this stock start to rally and you might want to consider this as a buy pre-market hours even.
NASDAQ:NVAXShort
by gamer456148
3
Novavax Technical and Fundamental AnalysisTechnical Analysis - Check/wait if one of the supports will not be broken before buying On a daily chart there might be a Bottom Saucer or Rounding Reversal Pattern Fundamental News: Novavax (NASDAQ:NVAX) is a clinical-stage biotechnology company focused on the discovery, development and commercialisation of vaccines and adjuvants. Through its recombinant nanoparticle vaccine technology, it produces vaccine candidates to respond to both known and newly emerging diseases. Novavax topped Wall Street expectations for the first quarter when it reported a loss of 58 cents per share on revenue of $3.4 million earlier this month. Analysts were expecting a loss of 69 cents per share and revenue of $1.9 million. More importantly, the biotech company announced in its earnings release that the Oslo-based nonprofit Coalition for Epidemic Preparedness Innovations will invest $384 million to advance the clinical development of its SARS-CoV-2 vaccine candidate, NVX-CoV2373. Novavax plans to start human trials in May with preliminary results expected in July.
NASDAQ:NVAX
by Mauriello
[NVAX] Sliding Back to $40, Collapse if It Breaks ThroughI missed this guy when I jumped on MRNA and INO earlier this week. Just trying to pin this one down a bit, coronavirus stocks are wild and fun :). For FOMO stocks, typical support and resistance horizontal lines aren't as predictive and you should instead look to the Volume Profile. Support should be right around the POC, which is $40. It should slide down to that and hang a bit before breaking through and crashing down. May bounce back up too but seems unlikely. All indicators are lining up at the start of a downward channel and signaling a short move too. June market crash is probably gonna move this more than anything as retail tries to secure their tiny profits or stem their massive losses.
NASDAQ:NVAXShort
by ProfitHarvest
8